New J Chem. 2010 Feb 12;2010(34):611-616 doi: 10.1039/b9nj00787c.

Effect of Peptide-Chelate Architecture on Metabolic Stability of Peptide-based MRI Contrast Agents

Zhang Z, Kolodziej AF, Qi J, Nair SA, Wang X, Case AW, Greenfield MT, Graham PB, McMurry TJ, Caravan P.

Abstract

A strategy for preparing high relaxivity, metabolically stable peptide-based MR contrast agents is described.

PMID: 20526382
PubMed Entry